Randomized evaluation of the beneficial effect of Livact in patients with heart failure complicated by hypoalbuminemia
Not Applicable
- Conditions
- heart failure patients complicated by hypoalbuminemia
- Registration Number
- JPRN-UMIN000004488
- Lead Sponsor
- niversity of Tokyo Hospital, Departement of Cardiovascular Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Not provided
Exclusion Criteria
1) Renal dysfunction (BUN over 40mg/dl or Cre over 2.0mg/dl 2) Nephrotic syndrome, or urine protein over 3+ 3) HbA1c over 8.0% 4) Liver cirrhosis 5) Patients with malignancy 6) Patients with abnormal branched-chain amino acid metabolism 7) Ventricular arrhythmia 8) Patients who need ventilator support. 9) Severe infectious disease 10) Patients who are enrolled in another clinical trial
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method